Neoplasms by Site Unknown Status Phase 3 Trials for Capecitabine (DB01101)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0030096 (Neoplasms by Site) | Unknown Status | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT01917279 | Capecitabine Maintenance Therapy Following Capecitabine Combined With Docetaxel in Treatment of mBC | Treatment |